Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Show Therapeutic Classes
Legacy Hazardous Drugs Do Not Tube List
QR Code Add Formweb to your mobile device
Android iOS
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Search results for:

risankizumab

risankizumab
Drug Name Form Strength Notes
Skyrizi (rzza) KIT, SUBCUTANEOUS 75 mg/0.83 mL
Skyrizi (rzza) SOLUTION, INTRAVENOUS 60 mg/mL
Skyrizi (rzza) Pen SOLUTION, SUBCUTANEOUS 150 mg/mL
Skyrizi (rzza) SOLUTION, SUBCUTANEOUS 360 mg/2.4 mL; 180 mg/1.2 mL
VIEW MORE Skin and Mucous Membrane Agents, Miscellaneous
Additional Information:

This medication is Inpatient Non-formulary and Restricted to Outpatient Use.  Inpatient use requires approval by a physician department leader (i.e. Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.  

See HERE for more information and workflow.

See HERE for additional pharmacy workflow details.

Last updated: Jan. 9, 2024






This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved